Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778368
What this trial is testing
A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma
Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)
Shanghai East Hospital 20